Allopregnanolone and mood disorders

@article{Bckstrm2014AllopregnanoloneAM,
  title={Allopregnanolone and mood disorders},
  author={T. B{\"a}ckstr{\"o}m and M. Bixo and M. Johansson and S. Nyberg and G. Wingen},
  journal={Progress in Neurobiology},
  year={2014},
  volume={113},
  pages={88-94}
}
  • T. Bäckström, M. Bixo, +2 authors G. Wingen
  • Published 2014
  • Medicine
  • Progress in Neurobiology
    • UNLABELLED Certain women experience negative mood symptoms during the menstrual cycle and progesterone addition in estrogen treatments. In women with PMDD increased negative mood symptoms related to allopregnanolone increase during the luteal phase of ovulatory menstrual cycles. In anovulatory cycles no symptom or sex steroid increase occurs. This is unexpected as positive modulators of the GABA-A receptor are generally increasing mood. This paradoxical effect has brought forward a hypothesis… CONTINUE READING
    View on Elsevier
    doi.org
    111 Citations
    Highly Influential Citations
    6
    Background Citations
    42
    Methods Citations
    4
    Results Citations
    2

    Paper Mentions

    Observational Clinical Trial
    Pregnancy and Anxious Thoughts: The Role of the Immune and Endocrine Systems
    The aim of the proposed research is to identify the clinical and biological phenotypes that define perinatal anxiety. The importance of this research to public health is that it will… Expand
    ConditionsPerinatal Anxiety
    InterventionOther
    Johns Hopkins University
    June 2016 - June 2022
    Blog Post
    ブレキサノロン , Brexanolone, Allopregnanolone
    New Drug Approvals
    21 March 2019
    News Article
    Prozac and PMS – how antidepressants could help with that painful time of the month
    The Conversation
    22 December 2014
    111 Citations
    Citation Type

    Citation Type

    GABAA Receptor-Modulating Steroids in Relation to Women’s Behavioral Health
    • 14
    Effects of GABA active steroids in the female brain with a focus on the premenstrual dysphoric disorder
    • 24
    • PDF
    Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls—a pilot study
    • 34
    Allopregnanolone and reproductive psychiatry: an overview
    • 7
    The role of ovarian hormone-derived neurosteroids on the regulation of GABAA receptors in affective disorders
    • 41
    • Highly Influenced
    Hormonal Contraception and Depression: Updated Evidence and Implications in Clinical Practice
    Progesterone, reproduction, and psychiatric illness.
    Negative Association Between Allopregnanolone and Cerebral Serotonin Transporter Binding in Healthy Women of Fertile Age
    • 7
    • PDF
    Prefrontal GABA concentration changes in women—Influence of menstrual cycle phase, hormonal contraceptive use, and correlation with premenstrual symptoms
    • 53
    • PDF
    GABAA dysregulation as an explanatory model for late-onset postpartum depression associated with weaning and resumption of menstruation
    • 5
    • Highly Influenced
    • PDF

    References

    SHOWING 1-10 OF 94 REFERENCES
    The Role of Hormones and Hormonal Treatments in Premenstrual Syndrome
    • 145
    • PDF
    Allopregnanolone concentration and mood—a bimodal association in postmenopausal women treated with oral progesterone
    • 62
    • PDF
    Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: A pilot study
    • 125
    Progesterone selectively increases amygdala reactivity in women
    • 201
    • PDF
    Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome
    • 49
    • PDF
    Pharmacokinetic and behavioral effects of allopregnanolone in healthy women
    • 117
    • PDF
    Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome.
    • 591
    GABAA receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid
    • 502
    Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences.
    • 348
    • PDF
    Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone
    • 95
    • PDF